摘要
Covering: up to 2025Toll-like receptor 2 (TLR2) is a versatile pattern recognition receptor whose activity can be tuned in either direction-agonism or antagonism-to produce distinct therapeutic outcomes, ranging from vaccine adjuvants and cancer immunotherapeutics to anti-inflammatory agents for sepsis, neuroinflammation, and autoimmune disease. Natural products from bacteria, fungi, plants, and marine organisms have emerged as a structurally rich source of TLR2 modulators, encompassing acylated lipopeptides, glycolipids, polysaccharides, flavonoids, non-flavonoid polyphenols, an aromatic aldehyde, an aporphine alkaloid, and even large bacterial antagonist proteins. This review surveys these natural TLR2 agonists and inhibitors, highlighting how the effective allocation of hydrophobic chains between the TLR2 pocket and its partner receptor, rather than total acyl-chain number alone, combines with chain branching, stereochemical presentation and polar head-group interactions to govern TLR1/TLR6 heterodimer selectivity among bacterial and gut-commensal lipids, and how mechanistically distinct inhibitory strategies-direct receptor competition, transcriptional downregulation, and TIR-domain interference-converge on a shared druggable interface exploited independently by plant polyphenols and staphylococcal virulence factors alike. Persistent experimental challenges are also discussed, including microbial contamination of natural extracts and structural heterogeneity of isolated lipids, along with how total synthesis and chemically defined oligomers have resolved these ambiguities, underscoring natural products as a promising yet still underexploited chemical space for developing selective TLR2-targeted therapeutics.